Effectiveness of Individualized Pelvic Floor Muscle Rehabilitation in Addition to Standard Urotherapy and Alarm Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis

This study will evaluate whether adding individualized pelvic floor muscle rehabilitation to standard urotherapy and alarm treatment improves bedwetting in children aged 5-18 years with primary monosymptomatic nocturnal enuresis. Participants will be randomly assigned to two groups. Both groups will receive standard urotherapy and alarm treatment. One group will also receive pelvic floor muscle rehabilitation for 12 weeks. The study will compare dry nights, alarm activations, and changes in pelvic floor muscle function between the groups.

Inclusion Criteria: * Diagnosis of primary monosymptomatic nocturnal enuresis (PMNE) according to the International Children's Continence Society (ICCS) diagnostic criteria. * Age between 5 and 18 years. * Willingness to participate in the study and provision of written informed consent by a parent or legal guardian. * Recommendation of enuresis alarm therapy as a first-line treatment. Exclusion Criteria: * Presence of cognitive or intellectual impairment. * Enuresis attributable to anatomical or neurological causes. * Receipt of nonpharmacological treatment for enuresis, such as standard urotherapy, alarm therapy, pelvic floor muscle training, or electrical stimulation, within the preceding six months.